Related references
Note: Only part of the references are listed.Preoperative Hypogonadism Is Not an Independent Predictor of High-Risk Disease in Patients Undergoing Radical Prostatectomy
Andrea Salonia et al.
CANCER (2011)
Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth
Abraham Morgentaler et al.
EUROPEAN UROLOGY (2009)
Two Years of Testosterone Therapy Associated with Decline in Prostate-Specific Antigen in a Man with Untreated Prostate Cancer
Abraham Morgentaler
JOURNAL OF SEXUAL MEDICINE (2009)
Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
Andrew W. Roddam et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The ratio of serum testosterone-to-prostate specific antigen predicts prostate cancer in hypogonadal men
Ernani Luis Rhoden et al.
JOURNAL OF UROLOGY (2008)
Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy
Shinya Yamamoto et al.
EUROPEAN UROLOGY (2007)
Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less
Abraham Morgentaler et al.
UROLOGY (2006)
Testosterone and prostate cancer: An historical perspective on a modern myth
Abraham Morgentaler
EUROPEAN UROLOGY (2006)
Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the gleason score
Tsutomu Nishiyama et al.
JOURNAL OF UROLOGY (2006)
Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: Hypogonadism represents bad prognosis in prostate cancer
C Teloken et al.
JOURNAL OF UROLOGY (2005)
Adverse events associated with testosterone replacement in middle-aged and older men: A meta-analysis of randomized, placebo-controlled trials
OM Calof et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2005)
Medical progress - Risks of testosterone-replacement therapy and recommendations for monitoring
EL Rhoden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
JC Massengill et al.
JOURNAL OF UROLOGY (2003)
Share Paper
